LEHI, Utah--(BUSINESS WIRE)--Nov 12, 2025-- Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet’s FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112744527/en/ Owlet partners with Rhapsody to securely connect infant vital signs from Owlet’s FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows.